Molecular landscape of osimertinib resistance revealed by targeted panel sequencing and patient-derived cancer models in non-small cell lung cancer patients

Authors :: Juliann Chmielecki
Min Kim
S.-Y. Kim
J.C. Barrett
H.R. Kim
C.-W. Park
S.G. Heo
Aleksandra Markovets
Minsun Hong
Daniel Stetson
H.-N. Kang
Byoung Chul Cho
Source :: Annals of Oncology. 29:viii516
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: 0301 basic medicine
business.industry
Cancer
Hematology
medicine.disease
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
Oncology
030220 oncology & carcinogenesis
Cancer research
Medicine
Osimertinib
Non small cell
business
Lung cancer

Tools